A chemotherapy drug or supportive care agent may be referred to by different names. Typically, when a drug is first approved by the TGA for clinical use, the tradename selected by the manufacturer is used. However, the same agent may also be referred to by its chemical name. Once the original manufacturers patent on the drug has expired, other manufacturers, with TGA approval, are allowed to produce and market the same chemical compound which is typically referred to as a “generic” form of the original. Sometimes these manufacturers will market the generic form under a new tradename to help identify it in the marketplace. Finally, the actual chemical name of the compound is sometimes used by medical professionals rather than the tradename or generic name.
NPS is an independent, not-for-profit organisation providing practical tools and information about medicines, health conditions and medical tests.
This helps individuals and health professionals be medicinewise, making better informed choices about their health.
NPS help health professionals keep up to date with the latest evidence and provide individuals with the tools and knowledge to make better decisions.
NPS maintain a database of over 1500 prescription and pharmacist-only medicines. You can search to find relevant and up to date consumer medicine information leaflets (CMIs).